JP2023524071A5 - - Google Patents

Info

Publication number
JP2023524071A5
JP2023524071A5 JP2022566343A JP2022566343A JP2023524071A5 JP 2023524071 A5 JP2023524071 A5 JP 2023524071A5 JP 2022566343 A JP2022566343 A JP 2022566343A JP 2022566343 A JP2022566343 A JP 2022566343A JP 2023524071 A5 JP2023524071 A5 JP 2023524071A5
Authority
JP
Japan
Prior art keywords
mrna
mol
pharmaceutical composition
lipid
chemically modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022566343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524071A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/030257 external-priority patent/WO2021222801A2/en
Publication of JP2023524071A publication Critical patent/JP2023524071A/ja
Publication of JP2023524071A5 publication Critical patent/JP2023524071A5/ja
Pending legal-status Critical Current

Links

JP2022566343A 2020-05-01 2021-04-30 嚢胞性線維症を治療するための核酸及び方法 Pending JP2023524071A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063019170P 2020-05-01 2020-05-01
US63/019,170 2020-05-01
US202063082997P 2020-09-24 2020-09-24
US63/082,997 2020-09-24
PCT/US2021/030257 WO2021222801A2 (en) 2020-05-01 2021-04-30 Nucleic acids and methods of treatment for cystic fibrosis

Publications (2)

Publication Number Publication Date
JP2023524071A JP2023524071A (ja) 2023-06-08
JP2023524071A5 true JP2023524071A5 (cg-RX-API-DMAC7.html) 2024-05-10

Family

ID=78374030

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022566343A Pending JP2023524071A (ja) 2020-05-01 2021-04-30 嚢胞性線維症を治療するための核酸及び方法

Country Status (7)

Country Link
US (2) US12070509B2 (cg-RX-API-DMAC7.html)
EP (1) EP4143217A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023524071A (cg-RX-API-DMAC7.html)
AU (1) AU2021263590A1 (cg-RX-API-DMAC7.html)
CA (1) CA3176844A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ794954A (cg-RX-API-DMAC7.html)
WO (1) WO2021222801A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11801227B2 (en) 2016-05-18 2023-10-31 Modernatx, Inc. Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
WO2021222801A2 (en) * 2020-05-01 2021-11-04 Arcturus Therapeutics, Inc. Nucleic acids and methods of treatment for cystic fibrosis
CN116368226A (zh) 2020-09-04 2023-06-30 维乎医疗有限公司 用于加帽rna的组合物和方法
CN117098541A (zh) 2020-11-25 2023-11-21 阿卡格拉医药公司 用于递送核酸的脂质纳米粒及相关使用方法
MX2023011227A (es) 2021-03-22 2023-12-06 Recode Therapeutics Inc Composiciones y metodos para administracion dirigida a celulas.
MX2023011243A (es) 2021-03-23 2023-12-14 Recode Therapeutics Inc Composiciones de polinucleotidos, formulaciones relacionadas y metodos de uso de los mismos.
EP4334330A1 (en) 2021-05-07 2024-03-13 Helix Nanotechnologies, Inc. Modified ribonucleic acids and uses thereof
EP4763287A2 (en) 2021-09-03 2026-06-24 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
EP4469091A1 (en) 2022-01-28 2024-12-04 CureVac SE Nucleic acid encoded transcription factor inhibitors
WO2023230587A2 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
CA3248209A1 (en) 2022-05-25 2023-11-30 CureVac SE Escherichia coli Antigenic Polypeptide-Based Nucleic Acid Vaccine (FIMH)
WO2024089229A1 (en) 2022-10-28 2024-05-02 CureVac SE Improved formulations comprising lipid-based carriers encapsulating rna
KR20250153298A (ko) 2023-03-08 2025-10-24 큐어백 에스이 핵산 전달을 위한 신규의 지질 나노입자 제형
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
US20250144237A1 (en) * 2023-11-07 2025-05-08 Cila Therapeutics Inc. Agents, compositions and methods for enhanced delivery of nucleic acids to the cells within the respiratory system
WO2025103803A1 (en) 2023-11-13 2025-05-22 CureVac SE Immunotherapy against neuronal and brain tumors
US12364773B2 (en) 2023-12-01 2025-07-22 Recode Therapeutics, Inc. Lipid nanoparticle compositions and uses thereof
WO2026072721A1 (en) * 2024-09-25 2026-04-02 Carbon Biosciences, Inc. Parvovirus compositions and methods for gene therapy

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0079963B1 (en) 1981-06-04 1986-08-27 Delaware Chemicals Corporation Pressurized container with dispensing pump
US4778810A (en) 1987-01-08 1988-10-18 Nastech Pharmaceutical Co., Inc. Nasal delivery of caffeine
AU649074B2 (en) 1990-10-12 1994-05-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Modified ribozymes
US5652094A (en) 1992-01-31 1997-07-29 University Of Montreal Nucleozymes
US5780014A (en) 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
KR20040051450A (ko) * 2002-12-12 2004-06-18 주식회사 인비보사이언스 알엔에이의 생체내 안정성을 증가시키는 벡터
EP2049665A2 (en) 2006-07-28 2009-04-22 Applera Corporation Dinucleotide mrna cap analogs
WO2009058911A2 (en) 2007-10-31 2009-05-07 Applied Biosystems Inc. Preparation and isolation of 5' capped mrna
EP3100718B1 (en) 2008-01-02 2019-11-27 Arbutus Biopharma Corporation Improved compositions and methods for the delivery of nucleic acids
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
AU2009303345B2 (en) 2008-10-09 2015-08-20 Arbutus Biopharma Corporation Improved amino lipids and methods for the delivery of nucleic acids
WO2010048536A2 (en) 2008-10-23 2010-04-29 Alnylam Pharmaceuticals, Inc. Processes for preparing lipids
EP3699172A3 (en) 2008-11-10 2020-11-18 Arbutus Biopharma Corporation Novel lipids and compositions for the delivery of therapeutics
EP2391343B1 (en) 2009-01-29 2017-03-01 Arbutus Biopharma Corporation Improved lipid formulation for the delivery of nucleic acids
CA3042927C (en) 2009-05-05 2022-05-17 Arbutus Biopharma Corporation Lipid compositions for the delivery of therapeutic agents
KR20220038506A (ko) 2009-06-10 2022-03-28 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
EP4481047A3 (en) 2010-06-03 2025-04-16 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
WO2013151664A1 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins
CN104411338A (zh) * 2012-04-02 2015-03-11 现代治疗公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
KR102311614B1 (ko) 2013-03-14 2021-10-08 샤이어 휴먼 지네틱 테라피즈 인크. Cftr mrna 조성물 및 관련 방법 및 사용
EP3052511A4 (en) 2013-10-02 2017-05-31 Moderna Therapeutics, Inc. Polynucleotide molecules and uses thereof
EP3574923A1 (en) 2013-10-22 2019-12-04 Translate Bio, Inc. Mrna therapy for phenylketonuria
CN110003066B (zh) * 2013-11-18 2021-09-03 阿克丘勒斯治疗公司 用于rna递送的可电离的阳离子脂质
WO2016070166A2 (en) 2014-11-02 2016-05-06 Arcturus Therapeutics, Inc. Messenger una molecules and uses thereof
DK4276189T3 (da) 2015-09-21 2026-05-26 Trilink Biotechnologies Llc Initierende oligonukleotidprimere med kappe til syntesering af 5'-ende RNA'er med kappe
US10487105B2 (en) 2016-10-19 2019-11-26 Arcturus Therapeutics, Inc. Trinucleotide MRNA cap analogs
WO2018119163A1 (en) * 2016-12-21 2018-06-28 Payne Joseph E Ionizable cationic lipid for rna delivery
MX2019010155A (es) * 2017-02-27 2020-12-10 Translate Bio Inc Arnm de cftr optimizado por codón novedoso.
EP3589290A4 (en) 2017-02-28 2020-12-30 Arcturus Therapeutics, Inc. Translatable molecules and synthesis thereof
US11015204B2 (en) * 2017-05-31 2021-05-25 Arcturus Therapeutics, Inc. Synthesis and structure of high potency RNA therapeutics
WO2021222801A2 (en) * 2020-05-01 2021-11-04 Arcturus Therapeutics, Inc. Nucleic acids and methods of treatment for cystic fibrosis
US20230159449A1 (en) * 2021-11-03 2023-05-25 Arcturus Therapeutics, Inc. Lipid formulations containing nucleic acids and methods of treatment for cystic fibrosis

Similar Documents

Publication Publication Date Title
JP2024542099A5 (cg-RX-API-DMAC7.html)
Persson et al. Patient‐controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan.
TW200918051A (en) Treatment of progressive neurodegenerative disease with ibudilast
EP1785145A1 (en) Transnasal composition having immediate action and high absorbability
Gilliard et al. Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury
PT1054664E (pt) Método para modulação da ativação de macrófagos
CN114404391B (zh) 一种纳米粒及其制备方法和用途
Mizuguchi et al. Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth
WO2025008006A1 (zh) 脂质化合物和脂质纳米颗粒组合物
EP3829539A1 (en) Sustained-release compositions comprising a therapeutic agent for treating depression or anxiety and uses thereof
TW202023618A (zh) 含鎮靜藥物之緩釋藥物組合物及其用途
PT92995B (pt) Metodo para o tratamento da disfuncao leucocita com gm-csf
EP1642591A1 (en) MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME
JP2008512444A (ja) 神経変性状態の治療のための、両親媒性弱塩基様テンパミンを含むリポソーム製剤
CN117442552A (zh) 一种淋巴结内t细胞区靶向纳米粒及其水凝胶
EP3768323A1 (en) Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers
TW202021574A (zh) 含有抗精神病藥物的緩釋藥物組合物及其用途
CN116370438A (zh) 一种载药复合纳米粒子MSN-Ber的制备方法以及在制备治疗肺纤维化的药物中的应用
CN118340915A (zh) 一种细胞因子装载系统及制备方法和应用
WO2023169506A1 (zh) 编码新型冠状病毒S蛋白的mRNA疫苗
WO2019024841A1 (zh) 一种用于治疗造血系统增殖性疾病的纳米脂质微粒组合物及药物组合物
RU2828768C1 (ru) Применение липосом с гидрохлоридом митоксантрона и циклофосфамида, винкристина и преднизона
CN102138900B (zh) 奥沙碘铵脂质体固体制剂
Saeinasab et al. Encapsulation in respiratory system
CN118512414A (zh) 一种具有器官靶向能力的低免疫原性脂质纳米粒及其制备方法与应用